Table 3.
Univariate and multivariate analyses of CCND1 expression in BCR-free survival time analysis.
| Univariate | BCR-free survival time | |
|---|---|---|
| HR (95% CI) | P | |
| Low IE score (cytoplasmic) | 1 | |
| High IE score (cytoplasmic) | 0.536 (0.362-0.793) | 0.002 |
| Low IE score (nuclear) | 1 | |
| High IE score (nuclear) | 0. 816 (0.561-1.186) | 0.286 |
| Multivariate | ||
| IE score (cytoplasmic) (low/high) | 0.774 (0.504-1.189) | 0.242 |
| pT stage (pT2/pT3, pT4) | 1.736 (1.128-2.672) | 0.012 |
| pN stage (pNx, pN0/pN1) | 2.560 (1.576-4.159) | <0.001 |
| Gleason score (<4 + 4/≥4 + 4) | 2.011 (1.337-3.026) | 0.001 |
| PSA level (>10/≤10) | 2.096 (1.147-3.829) | 0.016 |